ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,437Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 336

$778K Total Retail Price of All Prescriptions

Rank: 73 out of 336

497 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 15,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
PRAVASTATIN SODIUM 678 562 1 10
AMLODIPINE BESYLATE 675 605 2 1
OMEPRAZOLE 526 453 3 3
HYDROCODONE-ACETAMINOPHEN 443 399 S3 4 2
METFORMIN HCL 427 341 5 8
LEVOTHYROXINE SODIUM 378 361 6 7
GABAPENTIN 374 311 7 11
CARVEDILOL 369 328 8 13
POTASSIUM CHLORIDE 344 290 9 9
ATORVASTATIN CALCIUM 344 288 9 14
FUROSEMIDE 334 306 11 4
LISINOPRIL 268 237 12 6
DONEPEZIL HCL 267 263 13 27
LANTUS 259 227 14 56
DIOVAN 249 244 15 31
METOPROLOL SUCCINATE 242 217 16 15
CLONIDINE HCL 236 207 17 32
HYDROCHLOROTHIAZIDE 232 215 18 12
GLIPIZIDE 230 187 19 71
SPIRONOLACTONE 229 195 20 42
MIRTAZAPINE 209 204 21 66
ALENDRONATE SODIUM 199 198 22 54
ATENOLOL 196 191 23 26
LOSARTAN POTASSIUM 188 152 24 22
MELOXICAM 185 151 25 19
NAMENDA 182 176 26 39
ENALAPRIL MALEATE 180 159 27 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 132 28 23
ALLOPURINOL 160 137 29 30
WARFARIN SODIUM 159 132 30 17
METOPROLOL TARTRATE 158 155 31 16
FLUTICASONE PROPIONATE 154 132 32 49
JANTOVEN 146 146 33 125
TRAMADOL HCL 143 119 34 20
FLUOXETINE HCL 139 102 35 81
TAMSULOSIN HCL 131 109 36 38
LOVASTATIN 129 106 37 34
ISOSORBIDE MONONITRATE ER 128 126 38 44
METOCLOPRAMIDE HCL 128 96 38 123
SIMVASTATIN 125 114 40 5
PREDNISONE 121 107 41 48
NEXIUM 119 98 42 24
SERTRALINE HCL 118 99 43 33
LABETALOL HCL 111 100 44 194
TIZANIDINE HCL 110 97 45 83
POLYETHYLENE GLYCOL 3350 110 102 45 68
DIOVAN HCT 104 90 47 41
HYDRALAZINE HCL 96 82 48 53
CLOPIDOGREL 96 81 48 28
TRAZODONE HCL 94 75 50 46
CITALOPRAM HBR 89 87 51 21
AMLODIPINE BESYLATE-BENAZEPRIL 87 73 52 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 78 53 89
SOTALOL 84 81 54 259
HUMALOG 81 45 55 214
JANUVIA 75 48 56 67
CRESTOR 74 72 57 25
SYNTHROID 73 73 58 43
PANTOPRAZOLE SODIUM 73 69 58 40
GEMFIBROZIL 71 65 60 115
PROAIR HFA 71 59 60 77
LOSARTAN-HYDROCHLOROTHIAZIDE 71 57 60 45
LYRICA 69 48 63 70
PLAVIX 68 60 64 37
CYMBALTA 67 56 65 52
RANITIDINE HCL 67 67 65 36
LIPITOR 67 63 65 62
DETROL LA 65 58 68 175
AMITRIPTYLINE HCL 64 58 R 69 57
TRIAMTERENE-HCTZ 63 63 70 35
IPRATROPIUM BROMIDE 61 61 71 236
KLOR-CON 10 60 57 72 75
BUSPIRONE HCL 60 60 72 113
INSULIN SYRINGE 58 45 74 102
DOXYCYCLINE HYCLATE 57 53 75 92
VERAPAMIL ER 56 56 76 95
KLOR-CON M20 56 46 76 51
GLYBURIDE 55 53 R 78 76
PAROXETINE HCL 54 54 79 64
IPRATROPIUM-ALBUTEROL 51 51 80 232
VENTOLIN HFA 51 41 80 130
ESCITALOPRAM OXALATE 50 50 82 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.